Strategic Combination Creates Premier Provider of Biotechnology Reagents and Systems
Transaction Valued at $6.7 Billion
Invitrogen Corporation (NASDAQ: IVGN) and Applera Corporation today announced that their Boards of Directors have approved a definitive merger agreement, under which Invitrogen will acquire all of the outstanding shares of Applera’s Applied Biosystems Group (NYSE: ABI) in a cash [...]